Radan Anda-Petronela, Renz Patricia, Raio Luigi, Villiger Anna-Sophie, Haesler Valérie, Trippel Mafalda, Surbek Daniel
Department of Obstetrics and Feto-Maternal Medicine, University Hospital of Bern, University of Bern, Bern, Switzerland.
Department for Biomedical Research, University of Bern, Bern, Switzerland.
Front Med (Lausanne). 2024 Sep 4;11:1439181. doi: 10.3389/fmed.2024.1439181. eCollection 2024.
Pregnant women are at increased risk for severe SARS-CoV-2 infection and adverse neonatal outcome, primarily preterm birth and stillbirth. Our study aimed to investigate to which extent SARS-CoV-2 affects placental tissue and if viral replication within the placenta is evident, thus if there is a correlation between placental damage and adverse pregnancy outcome such as stillbirth.
We prospectively collected placentas from 61 SARS-CoV-2 infected pregnant women and 10 controls. Histopathological, immunohistochemical, and hybridization studies were performed on all placentas with antibodies for SARS-CoV-2 proteins, ACE2, various immune cells, and inflammatory markers or probes for SARS-CoV-2 genes and an antisense strand.
The measured scores of SARS-CoV-2 glycoprotein, nucleocapsid, and antisense strand indicating replication correlated with both the severity of maternal symptoms and presence of stillbirth. Specifically, 15/61 placentas exhibited replication, while the three cases with stillbirth had high or maximal replication scores. ACE2-H-score was significantly higher in COVID-19 patients, while the expression of various immune cells did not differ statistically. In multivariate analysis, presence of maternal comorbidities correlated with presence of severe COVID-19 infection.
We report evidence of active SARS-CoV-2 replication in the placenta after maternal infection in pregnancy in a case-control setting in a large population. Intensity of placental viral replication as well as viral levels were higher in women with severe or critical COVID-19 disease, supporting the rationale that severity of maternal SARS-CoV-2 infection could correlate with the severity of placentitis. Replication was maximal in cases of stillbirth, which suggests direct placental involvement in the pathophysiology of this dramatic outcome. Continuing to advocate for preventive measures against COVID-19 during pregnancy, including (re)vaccination, as well as appropriately counseling women with diagnosed infection, are of utter importance.
孕妇感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及出现不良新生儿结局的风险增加,主要是早产和死产。我们的研究旨在调查SARS-CoV-2对胎盘组织的影响程度,以及胎盘内病毒复制是否明显,从而确定胎盘损伤与死产等不良妊娠结局之间是否存在关联。
我们前瞻性地收集了61例感染SARS-CoV-2的孕妇和10例对照的胎盘。对所有胎盘进行组织病理学、免疫组织化学和杂交研究,使用针对SARS-CoV-2蛋白、血管紧张素转换酶2(ACE2)、各种免疫细胞、炎症标志物的抗体,或针对SARS-CoV-2基因和反义链的探针。
表明病毒复制的SARS-CoV-2糖蛋白、核衣壳和反义链的测量得分与母亲症状的严重程度和死产的存在均相关。具体而言,61个胎盘中有15个表现出病毒复制,而3例死产病例的复制得分较高或最高。COVID-19患者的ACE2-H评分显著更高,而各种免疫细胞的表达在统计学上没有差异。多变量分析显示,母亲合并症的存在与严重COVID-19感染的存在相关。
我们报告了在大量人群的病例对照研究中,孕期母亲感染后胎盘内存在活跃的SARS-CoV-2复制的证据。患有严重或危重型COVID-19疾病的女性胎盘病毒复制强度及病毒水平更高,这支持了母亲SARS-CoV-2感染的严重程度可能与胎盘炎的严重程度相关的理论。死产病例中病毒复制最为显著,这表明胎盘直接参与了这一严重结局的病理生理过程。继续倡导孕期针对COVID-19的预防措施,包括(重新)接种疫苗,以及对确诊感染的女性进行适当的咨询,至关重要。